
Moderna’s Cancer Vaccine Trial Data: High Stakes for Stock and Biotech Sector
Moderna is set to release Phase 3 trial data for its personalized cancer vaccine this weekend, a binary catalyst that could significantly impact its stock and the broader biotech sector....























